Health News Releases

  • Today April 23
December 06, 2024 11:20
Vevo Therapeutics Partners with the Parse Biosciences GigaLab to Generate 100M Cell Atlas for AI Powered Drug Discovery
Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.parsebiosciences.com%2F&esheet=54161904&newsitemid=20241205693431&lan=en-US&anchor=Parse+Biosciences&index=1&md
Nurse Maria Victoria Juan from Philippines – Winner of Aster Guardians Global Nursing Award 2024 (Ph
December 05, 2024 13:50
Nurse Maria Victoria Juan From Philippines Wins the Prestigious Aster Guardians Global Nursing Award 2024
Nurse Maria Victoria Juan from Philippines, a Consultant at Philippines Army Health Services and Colonel, Reserve Force of the Armed Forces of the Philippines, has been announced as the winner of the
Charlene Dark, newly appointed chief operating officer of Avania. (Photo: Business Wire)
December 05, 2024 10:45
Avania Appoints Innovative Operations Strategist Charlene Dark as New Chief Operating Officer
Avania (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.avaniaclinical.com%2F&esheet=54160539&newsitemid=20241203677092&lan=en-US&anchor=Avania&index=1&md5=4b5f83247ba447bb7edd17
December 04, 2024 10:45
Takeda Strengthens Oncology Pipeline with Elritercept through Licensing Agreement with Keros Therapeutics
Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2F&esheet=54160718&newsitemid=20241202182459&lan=en-US&anchor=TSE%3A4502%2FNYSE%
Nihon Medi-Physics headquarters and woman looking at molecular imaging images (Photo: Business Wire)
December 02, 2024 14:15
GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical
GE HealthCare (Nasdaq: GEHC) has agreed to acquire full ownership of Nihon Medi-Physics Co., Ltd (NMP), by purchasing from Sumitomo Chemical (TYO: 4005) the 50% stake it does not already own. As part
November 29, 2024 09:23
Galderma’s Phase III OLYMPIA 1 Data Published in JAMA Dermatology Demonstrate That Nemolizumab Improves Core Signs and Symptoms of Prurigo Nodularis
Galderma (SWX:GALD) today announced that full results from the phase III OLYMPIA 1 trial, a 24-week study which evaluated the efficacy and safety of nemolizumab monotherapy in adults with moderate-to-
Portrait of Dr. Martin Steinhart, CEO AOP Health (Photo: AOP Health/Studio Koekart)
November 28, 2024 10:15
U.S. FDA Approves AOP Health’s Rapiblyk™ (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting
AOP Orphan Pharmaceuticals GmbH (AOP Health), based in Vienna, Austria, announced that the U.S. Food and Drug Administration (FDA) has granted regulatory approval for Rapiblyk™ (landiolol) in the hosp
November 27, 2024 16:00
Viromed Medical AG: Cold Plasma as a Digital Antibiotic for the Lungs
Viromed Medical AG (Ticker: VMED; ISIN: DE000A3MQR65; “Viromed”) is pushing forward research into cold plasma for the prevention of ventilator-associated pneumonia (VAP). Under the scientific directio
November 24, 2024 11:10
Novotech Publishes Comprehensive Report on the Global Vaccine Clinical Trials Landscape
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, ha
Ribbon Cutting of the Lab (Photo: Business Wire)
November 22, 2024 16:40
Rigaku BioScience Lab Opens in USA
Rigaku Corporation, a Rigaku Holdings Group company that serves as a global solution partner for X-ray analytical equipment (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; “Rigaku”), opened Rigaku
November 22, 2024 10:50
Global Cell and Gene Therapy Trials: Driving Innovation in Oncology and Beyond
Novotech, the global full-service clinical Contract Research Organization (CRO), has published its latest whitepaper, offering in-depth analysis and emerging trends and advancements within the rapidly
November 22, 2024 09:55
The Future of Diffuse Large B-Cell Lymphoma (DLBCL) Treatment: Insights from Global Research
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, sh
November 21, 2024 11:40
Novotech Releases Report on Global Bladder Cancer Clinical Trials, Offering Insights for Oncology Advancement
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, ha
November 20, 2024 17:10
NationsBenefits Acquires Good Measures to Revolutionize Food as Medicine Solutions
NationsBenefits®, the leading fintech, benefits, and outcomes platform for healthcare, announced the acquisition of Good Measures, the leading platform for Food as Medicine supporting health plans and
November 20, 2024 15:30
Pharmanovia Signs Novel Biologic In-Licensing Agreement With Lindis Biotech to Commercialise Catumaxomab for Treatment of Rare Condition, Malignant Ascites
Pharmanovia, a global pharmaceutical company that commercialises novel medicines and revitalises, extends and expands the lifecycle of established medicines, has today announced the expansion of its o
November 19, 2024 15:50
HistoSonics® Enrolls First Patients in Company’s Novel BOOMBOX Master Study
HistoSonics, the developer and manufacturer of the Edison® Histotripsy System, announced today the first patients were enrolled in their novel prospective master protocol study, called BOOMBOX, design
November 19, 2024 11:35
Novotech Releases Comprehensive Report on the Global Clinical Trial Landscape for Small Cell Lung Cancer (SCLC)
Novotech, the global full-service clinical Contract Research Organization (CRO), has published a new report, Small Cell Lung Cancer: Global Clinical Trial Landscape 2024 (https://cts.businesswire.com/
(Graphic: Business Wire)
November 17, 2024 15:40
BeiGene Unveils Proposed Name Change to BeOne Medicines, Reaffirming Its Mission to Unite Global Community Against Cancer
BeiGene, Ltd. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.beigene.com%2F&esheet=54152783&newsitemid=20241114671168&lan=en-US&anchor=BeiGene&index=1&md5=e4496ffaca181720a54a2
The structural model of amorphous carbon (left), estimated by TXS-RMC using SmartLab (right) (Graphi
November 15, 2024 16:00
Rigaku Develops Technology for 3D Visualization of the Atomic-scale Structure of Amorphous Carbon
The X-ray Laboratory of Rigaku Corporation, a Rigaku Holdings Group company and a global solution partner for X-ray analysis (headquarters: Akishima, Tokyo; president and CEO: Jun Kawakami; “Rigaku”),
(Graphic: Business Wire)
November 15, 2024 13:50
BeiGene Announces Third Quarter 2024 Financial Results and Corporate Updates
BeiGene (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.beigene.com%2F&esheet=54150961&newsitemid=20241112799807&lan=en-US&anchor=BeiGene&index=1&md5=4e5a672b984a991400376fd3071
November 15, 2024 11:10
Medidata Secures Highest Leadership Position in Everest Group’s First Life Sciences Clinical Trial Management System Products PEAK Matrix® Assessment
Medidata (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.medidata.com%2Fen%2F&esheet=54151986&newsitemid=20241112190210&lan=en-US&anchor=Medidata&index=1&md5=13f9038490d8f84d037
The new QPS Cell Therapy Unit in Springfield, Missouri is a Leukopak collection and blood product pr
November 14, 2024 14:00
QPS Launches New Leukopak and Cell Therapy Products Facility
QPS Holdings, LLC announced today that their Springfield campus, QPS Missouri, has launched a new Cell Therapy business unit. The unit’s first achievement is the opening of a new Leukopak collection a
November 14, 2024 11:10
Center for Disease Analysis Foundation Receives $7 Million Grant from the John C. Martin Foundation to Support the Polaris Observatory
The Center for Disease Analysis (CDA) Foundation is pleased to announce receipt of a $7 million grant from the John C. Martin Foundation to sustain and expand the Polaris Observatory until the end of
November 14, 2024 10:30
Novotech Releases In-Depth Report on Cervical Cancer: Addressing a Global Health Challenge
Novotech, the global full-service clinical Contract Research Organization (CRO), has released a new report, Cervical Cancer - Global Clinical Trial Landscape (https://cts.businesswire.com/ct/CT?id=sma
November 13, 2024 15:50
Medidata and Bioforum Bolster Decade-Long Relationship to Advance Clinical Data and Biometric Solutions for Clinical Trials
Medidata (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.medidata.com%2Fen%2F&esheet=54151261&newsitemid=20241112963841&lan=en-US&anchor=Medidata&index=1&md5=1aed735279447556547
25 per page50 per page75 per page100 per page